Brawn Biotech Ltd Stock Analysis

BSE: 530207 | NSE: | Trading | Small Cap

BSE Share Price 27-Jan-2023 18:01
18.35 0.55 (3.09%)

DeciZen - Make an Informed Decision on Brawn Biotech

M-Cap below 100cr DeciZen not available

Brawn Biotech Price Chart

P/E Ratio ( SA) :
Market Cap :
5.5 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Brawn Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Brawn Biotech Ltd is a average quality company.

2. Is Brawn Biotech Ltd undervalued or overvalued?

The key valuation ratios of Brawn Biotech Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Brawn Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Brawn Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Brawn Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Brawn Biotech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 9.3%6.3%7.5%19.9%16.6%17.8%15.9%6.3%-7.9%-20%-
Value Creation Index -0.3-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 25.937.838.746.960.655.865.249.6358.617
YoY Gr. Rt. %-45.9%2.3%21.3%29.2%-7.9%16.9%-23.9%-29.5%-75.4%-
Adj EPS 1.20.613.
YoY Gr. Rt. %--45.3%50%243.8%0.3%26.3%-1%-57.7%-241.1%NA-
BVPS (₹) 15.115.616.518.423.125.428.930.929.324.123.3
Adj Net Profit
Cash Flow from Ops.
Debt/CF from Ops. 0.300.52.4000000-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -11.5%-32.3%-49.1%-75.4%
Adj EPS -218.7%-210.7%-209.9%NA
BVPS 5.30.9-5.9-17.9
Share Price 7.2% -22.1% -14% -14.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 84.2618.915.917.215.35.9-8.2-20.6-16.3
Op. Profit Mgn %
Net Profit Mgn %
Debt to Equity 00000000000
Working Cap Days 17912912710585120122152171545147
Cash Conv. Cycle 23272828313227467027370

Recent Performance Summary

Sales growth is good in last 4 quarters at 96.50%

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Latest Financials - Brawn Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) -3.9 -
TTM Sales (₹ Cr.) 16.6 -
BVPS (₹.) 23.3 -
Reserves (₹ Cr.) 4 -
P/BV 0.79 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 13.60 / 23.30
All Time Low / High (₹) 0.40 / 95.60
Market Cap (₹ Cr.) 5.5
Equity (₹ Cr.) 3
Face Value (₹) 10
Industry PE 74.5

Management X-Ray of Brawn Biotech :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Brawn Biotech

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Brawn Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Brawn Biotech on 27-Jan-2023 18:01 is : 18.35.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Jan-2023 18:01 the market cap of Brawn Biotech stood at ₹ 5.51.
The latest PE ratio of Brawn Biotech as of 27-Jan-2023 18:01 is 0.00.
The latest PB ratio of Brawn Biotech as of 27-Jan-2023 18:01 is 0.79
The 52-week high of Brawn Biotech is ₹ 23.30 and the 52-week low is ₹ 13.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Brawn Biotech is ₹ 16.58 ( Cr.) .

About Brawn Biotech Ltd

Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company’s loan license basis. The company is located in New Delhi, India.

Business Profile:

The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically engages in the manufacture of tablets, capsules, and oral syrups.

Products of the company

Company's products are made under various categories namely Analgesics, Antibiotics, Anti Tuberculosis, Anti-inflammatory, Antipyretic, Anti Malarial, B Complex and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now